PAREA takes the stage at PSYCH Symposium 2025

On 4 December, Francisca Silva, Project Officer at PAREA, took part in PSYCH Symposium in London - this year co-organised with Drug Science. The symposium is one of Europe's leading gatherings for the industry’s most influential figures to connect, collaborate, and expedite the adoption of psychedelic healthcare.

Francisca participated in the panel “How to Integrate Psychedelic Therapies in Our Healthcare Systems” alongside Henrik and Andrea Jungaberle (MIND Foundation), Liliana Galindo (University of Cambridge), and UK MP Jeff Smith. The discussion focused on the pathways to integration of psychedelic therapies into healthcare systems, particularly public ones. Key topics included equity and accessibility, the role of political will and regulatory frameworks needed to support integration, and the importance of initiatives, such as Germany’s compassionate use programme, in paving the way alongside commercial development.

As psychedelic treatments approach marketing approvals, the panel highlighted the need to ensure that systems are prepared to provide responsible, equitable, and affordable access.

For other highlights from the event, follow Psychedelic Health’s wrap-up coverage here.